Advertisement
UK markets closed

  • FTSE 100

    8,213.49
    +41.34 (+0.51%)
     

  • FTSE 250

    20,164.54
    +112.21 (+0.56%)
     

  • AIM

    771.53
    +3.42 (+0.45%)
     

  • GBP/EUR

    1.1652
    -0.0031 (-0.26%)
     

  • GBP/USD

    1.2546
    +0.0013 (+0.11%)
     

  • Bitcoin GBP

    50,517.39
    +318.41 (+0.63%)
     

  • CMC Crypto 200

    1,317.30
    +40.33 (+3.16%)
     

  • S&P 500

    5,127.79
    +63.59 (+1.26%)
     

  • DOW

    38,675.68
    +450.02 (+1.18%)
     

  • CRUDE OIL

    77.99
    -0.96 (-1.22%)
     

  • GOLD FUTURES

    2,310.10
    +0.50 (+0.02%)
     

  • NIKKEI 225

    38,236.07
    -37.98 (-0.10%)
     

  • HANG SENG

    18,475.92
    +268.79 (+1.48%)
     

  • DAX

    18,001.60
    +105.10 (+0.59%)
     

  • CAC 40

    7,957.57
    +42.92 (+0.54%)
     
MONEY:

Best savings accounts that offer above inflation rates

Where to find a top-rated deal that works for you

Tecan Group Full Year 2023 Earnings: EPS Beats Expectations

editorial-team@simplywallst.com (Simply Wall St)
·1-min read

Tecan Group (VTX:TECN) Full Year 2023 Results

Key Financial Results

  • Revenue: CHF1.07b (down 6.1% from FY 2022).

  • Net income: CHF132.1m (up 9.0% from FY 2022).

  • Profit margin: 12% (up from 11% in FY 2022). The increase in margin was driven by lower expenses.

  • EPS: CHF10.34 (up from CHF9.53 in FY 2022).

revenue-and-expenses-breakdown
SWX:TECN Revenue and Expenses Breakdown March 15th 2024

All figures shown in the chart above are for the trailing 12 month (TTM) period

Tecan Group EPS Beats Expectations

Revenue was in line with analyst estimates. Earnings per share (EPS) surpassed analyst estimates by 14%.

The primary driver behind last 12 months revenue was the Partnering Business segment contributing a total revenue of CHF623.7m (58% of total revenue). Notably, cost of sales worth CHF683.9m amounted to 64% of total revenue thereby underscoring the impact on earnings. The largest operating expense was Sales & Marketing costs, amounting to CHF119.6m (46% of total expenses). Explore how TECN's revenue and expenses shape its earnings.

ADVERTISEMENT

Looking ahead, revenue is forecast to grow 6.8% p.a. on average during the next 3 years, compared to a 9.4% growth forecast for the Life Sciences industry in Switzerland.

Performance of the Swiss Life Sciences industry.

The company's share price is broadly unchanged from a week ago.

Balance Sheet Analysis

While it's very important to consider the profit and loss statement, you can also learn a lot about a company by looking at its balance sheet. We have a graphic representation of Tecan Group's balance sheet and an in-depth analysis of the company's financial position.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.